C2BBe1 In Vitro Telomere Length Analysis Assay (Senescence)

CAT#: ITS-1022-YF5401
Target Cell Organism: Human
Target Cell Name: C2BBe1
Assay Type: Cellular Senescence in Cancer Assays
Assay Overview
This assay is to provide C2BBe1-based In Vitro Telomere Length Analysis Assay (Senescence) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
C2BBe1
Target Cell Organism
Human
Target Cell Background
The C2BBe1 (brush border expressing) cell line was cloned in 1988 from the Caco-2 cell line by limiting dilution.
The clone was selected on the basis of morphological homogeneity and exclusive apical villin localization.
Related Diseases
Colorectal Adenocarcinoma; Colon Cancer
Research Area
Oncology
Assay Name
In Vitro Telomere Length Analysis Assay (Senescence)
Short Description
C2BBe1-cell based In Vitro Telomere Length Analysis Assay (Senescence)
Assay Description
For the analysis of telomere length, terminal restriction fragment analysis technique has been the commonly used technique for a long time.
Assay Type
Cellular Senescence in Cancer Assays
Assay Type Details
Cell senescence is described as an irreversible physiological event of cell growth arrest, which is known to be caused by alterations of telomeres, oxidative stress, DNA damage and some oncogenes. Inhibition of the program of senescence is one of the main features of tumor cells and it has been reported that cancer cells can be induced to undergo senescence by chemo- and radiotherapies and genetic alterations. Telomeres help to prevent uncontrolled cell proliferation and the absence of telomeres results in aneuploidy and cell death.
Assay Subtype
Telomere Length Analysis Assay
For Research Use Only | Not For Clinical Use
Online Inquiry